Combivent® nebuliser solution should be started only by a Respiratory Physician. It is less expensive to prescribe salbutamol and ipratropium bromide nebuliser solutions separately but this requires patients to nebulise 4.5 mL instead of 2.5 mL.

Only for patients already on a statin. Please note increased risk of AF

Mild papulopustular rosacea is usually managed by azelaic acid 15% gel. For moderate to severe inflammatory lesions of rosacea where a topical treatment is appropriate, ivermectin 1% cream should be used instead of topical metronidazole. Systemic antibiotics are reserved for more severe disease.

May only be initiated in primary care for people with type 2 diabetes and no heart failure.

May only be initiated in primary care for people with type 2 diabetes and no heart failure.

Can be initiated in primary care following specialist recommendation

Can be initiated in primary care following specialist recommendation

Can be initiated in primary care following specialist recommendation

May be prescribed in primary care on the recommendation / guidance of dermatology for the treatment of scabies

Apraclonidine 1% and 0.5% can be prescribed in primary care after Ophthalmic Consultant initiation. The 1% strength is sometimes used as complex glaucoma management in patients sensitive to preserved eye drops .

Fiasp (Fast acting insulin aspart) for patients 1 year and over under the care of the paediatric diabetes service, who are either unpredictable eaters or have problematic post-meal glucose rise, not managed with dietetic input and assessed as competent to try Fiasp by the dietician.

Fiasp (Fast acting insulin aspart) for patients 1 year and over under the care of the paediatric diabetes service, who are either unpredictable eaters or have problematic post-meal glucose rise, not managed with dietetic input and assessed as competent to try Fiasp by the dietician.

Fiasp (Fast acting insulin aspart) for patients 1 year and over under the care of the paediatric diabetes service, who are either unpredictable eaters or have problematic post-meal glucose rise, not managed with dietetic input and assessed as competent to try Fiasp by the dietician.

Approved for use in the treatment of type 1 diabetes mellitus in adults, adolescents and children from the age of one year, who are under the care of the paediatric diabetes service

Insulin degludec (Tresiba) - approved for use in the treatment of type 1 diabetes mellitus in adults, adolescents and children from the age of one year, who are under the care of the paediatric diabetes service.

Preparations For Warts And Calluses
For actinic keratosis for areas up to 25cm2. Please see Cornwall RMS for additional information

Insulin degludec (Tresiba) - approved for use in the treatment of type 1 diabetes mellitus in adults, adolescents and children from the age of one year, who are under the care of the paediatric diabetes service.

Apraclonidine 1% and 0.5% can be prescribed in primary care after Ophthalmic Consultant initiation. The 1% strength is sometimes used as complex glaucoma management in patients sensitive to preserved eye drops .

Xultophy, a combination of liraglutide/insulin degludec, is accepted onto the formulary for patients intolerant of at least two GLP-1 agonists and who may also be on insulin. Prescribing of Xultophy will be undertaken by the Diabetes Team for the first month and guidance on how Xultophy will be titrated up (and any existing insulin titrated down) will be provided by the Diabetes Team. Patients on Xultophy will be supervised by the Team for about 12 months.